MiR-361-5p promotes proliferation and inhibits apoptosis of fibroblast-like synoviocytes via targeting ZBTB10 in rheumatoid arthritis

References

• Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–2038.
   PubMed Web of Science ®Google Scholar
• Hyndman IJ. Rheumatoid arthritis: past, present and future approaches to treating the disease. Int J Rheum Dis. 2017;20(4):417–419.
   PubMed Web of Science ®Google Scholar
• De Cock D, Hyrich K. Malignancy and rheumatoid arthritis: epidemiology, risk factors and management. Best Pract Res Clin Rheumatol. 2018;32(6):869–886.
   PubMed Web of Science ®Google Scholar
• Pisetsky DS. Advances in the treatment of rheumatoid arthritis: costs and challenges. N C Med J. 2017;78(5):337–340.
   PubMedGoogle Scholar
• Song X, Lin Q. Genomics, transcriptomics and proteomics to elucidate the pathogenesis of rheumatoid arthritis. Rheumatol Int. 2017;37(8):1257–1265.
   PubMed Web of Science ®Google Scholar
• Orr C, Vieira-Sousa E, Boyle DL, et al. Synovial tissue research: a state-of-the-art review. Nat Rev Rheumatol. 2017;13(8):463–475.
   PubMed Web of Science ®Google Scholar
• Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233(1):233–255.
   PubMed Web of Science ®Google Scholar
• Xu R, Zhang F, Chai R, et al. Exosomes derived from pro-inflammatory bone marrow-derived mesenchymal stem cells reduce inflammation and myocardial injury via mediating macrophage polarization. J Cell Mol Med. 2019;23(11):7617–7631.
   PubMed Web of Science ®Google Scholar
• Chen Z, Wang H, Xia Y, et al. Therapeutic potential of mesenchymal cell-derived miRNA-150-5p-expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF. J Immunol. 2018;201(8):2472–2482.
   PubMed Web of Science ®Google Scholar
• Evangelatos G, Fragoulis GE, Koulouri V, et al. MicroRNAs in rheumatoid arthritis: from pathogenesis to clinical impact. Autoimmun Rev. 2019;18(11):102391.
   PubMed Web of Science ®Google Scholar
• Su LC, Huang AF, Jia H, et al. Role of microRNA-155 in rheumatoid arthritis. Int J Rheum Dis. 2017;20(11):1631–1637.
   PubMed Web of Science ®Google Scholar
• Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141(4):1202–1207.
   PubMed Web of Science ®Google Scholar
• Tiwari A, Mukherjee B, Dixit M. MicroRNA key to angiogenesis regulation: miRNA biology and therapy. Curr Cancer Drug Targets. 2018;18(3):266–277.
   PubMed Web of Science ®Google Scholar
• Dunaeva M, Blom J, Thurlings R, et al. Circulating serum miR-223-3p and miR-16-5p as possible biomarkers of early rheumatoid arthritis. Clin Exp Immunol. 2018;193(3):376–385.
   PubMed Web of Science ®Google Scholar
• Qiu M, Mo L, Li J, et al. Effects of miR-150-5p on the growth and SOCS1 expression of rheumatoid arthritis synovial fibroblasts. Clin Rheumatol. 2020;39(3):909–917.
   PubMedGoogle Scholar
• Singh A, Patro PS, Aggarwal A. MicroRNA-132, miR-146a, and miR-155 as potential biomarkers of methotrexate response in patients with rheumatoid arthritis. Clin Rheumatol. 2019;38(3):877–884.
   PubMed Web of Science ®Google Scholar
• Reyes-Long S, Cortes-Altamirano JL, Clavijio-Cornejo D, et al. Nociceptive related microRNAs and their role in rheumatoid arthritis. Mol Biol Rep. 2020;47(9):7265–7272.
   PubMedGoogle Scholar
• Ma F, Zhang L, Ma L, et al. MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1. J Exp Clin Cancer Res. 2017;36(1):158.
   PubMedGoogle Scholar
• Liu J, Yang J, Yu L, et al. miR-361-5p inhibits glioma migration and invasion by targeting SND1. Onco Targets Ther. 2018;11:5239–5252.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Liu X, Xu H, et al. Obesity-induced upregulation of miR-361-5p promotes hepatosteatosis through targeting Sirt1. Metabolism. 2018;88:31–39.
   PubMedGoogle Scholar
• Romo-Garcia MF, Bastian Y, Zapata-Zuniga M, et al. Identification of putative miRNA biomarkers in early rheumatoid arthritis by genome-wide microarray profiling: a pilot study. Gene. 2019;720:144081.
   PubMed Web of Science ®Google Scholar
• Zhang W, Li B, Xia N, et al. lncRNA GAS5 suppresses rheumatoid arthritis by inhibiting miR-361-5p and increasing PDK4. Biochem Biophys Res Commun. 2021;583:7–13.
   PubMed Web of Science ®Google Scholar
• Littlejohn EA, Monrad SU. Early diagnosis and treatment of rheumatoid arthritis. Prim Care. 2018;45(2):237–255.
   PubMed Web of Science ®Google Scholar
• Bustamante MF, Garcia-Carbonell R, Whisenant KD, et al. Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther. 2017;19(1):110.
   PubMedGoogle Scholar
• Ma JD, Jing J, Wang JW, et al. A novel function of artesunate on inhibiting migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Res Ther. 2019;21(1):153.
   PubMedGoogle Scholar
• de Oliveira PG, Farinon M, Sanchez-Lopez E, et al. Fibroblast-Like synoviocytes glucose metabolism as a therapeutic target in rheumatoid arthritis. Front Immunol. 2019;10:1743.
   PubMed Web of Science ®Google Scholar
• Shi Y, Wu Q, Xuan W, et al. Transcription factor SOX5 promotes the migration and invasion of fibroblast-like synoviocytes in part by regulating MMP-9 expression in collagen-induced arthritis. Front Immunol. 2018;9:749.
   PubMed Web of Science ®Google Scholar
• Rana AK, Li Y, Dang Q, et al. Monocytes in rheumatoid arthritis: circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity role in RA pathogenesis. Int Immunopharmacol. 2018;65:348–359.
   PubMed Web of Science ®Google Scholar
• Wang Y, Feng T, Duan S, et al. miR-155 promotes fibroblast-like synoviocyte proliferation and inflammatory cytokine secretion in rheumatoid arthritis by targeting FOXO3a. Exp Ther Med. 2020;19(2):1288–1296.
   PubMed Web of Science ®Google Scholar
• Guo T, Ding H, Jiang H, et al. miR-338-5p regulates the viability, proliferation, apoptosis and migration of rheumatoid arthritis fibroblast-like synoviocytes by targeting NFAT5. Cellular physiology and biochemistry. Cell Physiol Biochem. 2018;49(3):899–910.
   PubMedGoogle Scholar
• Yu FY, Xie CQ, Jiang CL, et al. MiR-92a inhibits fibroblast-like synoviocyte proliferation and migration in rheumatoid arthritis by targeting AKT2. J Biosci. 2018;43(5):911–919.
   PubMed Web of Science ®Google Scholar
• Perez-Torrado R, Yamada D, Defossez PA. Born to bind: the BTB protein-protein interaction domain. Bioessays. 2006;28(12):1194–1202.
   PubMedGoogle Scholar
• Bluhm A, Viceconte N, Li F, et al. ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2. Nucleic Acids Res. 2019;47(4):1896–1907.
   PubMedGoogle Scholar
• Tang W, Zhu J, Su S, et al. MiR-27 as a prognostic marker for breast cancer progression and patient survival. PLoS One. 2012;7(12):e51702.
   PubMed Web of Science ®Google Scholar